Logo image of QSI

QUANTUM-SI INC (QSI) Stock Fundamental Analysis

USA - NASDAQ:QSI - US74765K1051 - Common Stock

1.5 USD
-0.03 (-1.96%)
Last: 9/19/2025, 8:00:01 PM
1.53 USD
+0.03 (+2%)
After Hours: 9/19/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QSI. QSI was compared to 55 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for QSI as it has an excellent financial health rating, but there are worries on the profitability. QSI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QSI had negative earnings in the past year.
QSI had a negative operating cash flow in the past year.
QSI had negative earnings in each of the past 5 years.
QSI had a negative operating cash flow in each of the past 5 years.
QSI Yearly Net Income VS EBIT VS OCF VS FCFQSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -41.85%, QSI is doing worse than 81.82% of the companies in the same industry.
QSI's Return On Equity of -48.18% is on the low side compared to the rest of the industry. QSI is outperformed by 67.27% of its industry peers.
Industry RankSector Rank
ROA -41.85%
ROE -48.18%
ROIC N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
QSI Yearly ROA, ROE, ROICQSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

QSI's Gross Margin of 53.17% is in line compared to the rest of the industry. QSI outperforms 60.00% of its industry peers.
The Profit Margin and Operating Margin are not available for QSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QSI Yearly Profit, Operating, Gross MarginsQSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

7

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QSI has been increased compared to 1 year ago.
QSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QSI Yearly Shares OutstandingQSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
QSI Yearly Total Debt VS Total AssetsQSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that QSI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of QSI (1.47) is comparable to the rest of the industry.
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACCN/A
WACC10.45%
QSI Yearly LT Debt VS Equity VS FCFQSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

QSI has a Current Ratio of 9.43. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
QSI's Current ratio of 9.43 is amongst the best of the industry. QSI outperforms 90.91% of its industry peers.
QSI has a Quick Ratio of 9.27. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 9.27, QSI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.43
Quick Ratio 9.27
QSI Yearly Current Assets VS Current LiabilitesQSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for QSI have decreased by -7.94% in the last year.
The Revenue has grown by 100.82% in the past year. This is a very strong growth!
EPS 1Y (TTM)-7.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)100.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.98%

3.2 Future

Based on estimates for the next years, QSI will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.27% on average per year.
The Revenue is expected to grow by 112.04% on average over the next years. This is a very strong growth
EPS Next Y20.34%
EPS Next 2Y13.31%
EPS Next 3Y12.06%
EPS Next 5Y10.27%
Revenue Next Year-5.95%
Revenue Next 2Y73.3%
Revenue Next 3Y129.76%
Revenue Next 5Y112.04%

3.3 Evolution

QSI Yearly Revenue VS EstimatesQSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
QSI Yearly EPS VS EstimatesQSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QSI Price Earnings VS Forward Price EarningsQSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QSI Per share dataQSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

QSI's earnings are expected to grow with 12.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.31%
EPS Next 3Y12.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QSI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM-SI INC

NASDAQ:QSI (9/19/2025, 8:00:01 PM)

After market: 1.53 +0.03 (+2%)

1.5

-0.03 (-1.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners29.4%
Inst Owner Change11.35%
Ins Owners5.05%
Ins Owner Change-0.15%
Market Cap303.75M
Analysts77.14
Price Target2.72 (81.33%)
Short Float %14.13%
Short Ratio3.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.91%
Min EPS beat(2)-13.15%
Max EPS beat(2)28.97%
EPS beat(4)2
Avg EPS beat(4)0.61%
Min EPS beat(4)-21.99%
Max EPS beat(4)28.97%
EPS beat(8)6
Avg EPS beat(8)9.14%
EPS beat(12)9
Avg EPS beat(12)7.13%
EPS beat(16)11
Avg EPS beat(16)2.94%
Revenue beat(2)0
Avg Revenue beat(2)-31.91%
Min Revenue beat(2)-51.79%
Max Revenue beat(2)-12.03%
Revenue beat(4)0
Avg Revenue beat(4)-23.85%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)-3.79%
Revenue beat(8)2
Avg Revenue beat(8)-13.91%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.88%
PT rev (3m)-5.88%
EPS NQ rev (1m)2.38%
EPS NQ rev (3m)2.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.82%
Revenue NQ rev (1m)-1.38%
Revenue NQ rev (3m)-56.37%
Revenue NY rev (1m)-34.02%
Revenue NY rev (3m)-45.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 89.02
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.37
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS0.02
BVpS1.09
TBVpS1.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.85%
ROE -48.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.17%
FCFM N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 94.93%
Cap/Sales 118.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.43
Quick Ratio 9.27
Altman-Z 1.47
F-Score3
WACC10.45%
ROIC/WACCN/A
Cap/Depr(3y)214.69%
Cap/Depr(5y)249.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y20.34%
EPS Next 2Y13.31%
EPS Next 3Y12.06%
EPS Next 5Y10.27%
Revenue 1Y (TTM)100.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.98%
Revenue Next Year-5.95%
Revenue Next 2Y73.3%
Revenue Next 3Y129.76%
Revenue Next 5Y112.04%
EBIT growth 1Y-6.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.28%
EBIT Next 3Y5.81%
EBIT Next 5Y5.25%
FCF growth 1Y5.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.67%
OCF growth 3YN/A
OCF growth 5YN/A